Table 2 Details of insulin-dextrose treatment and glucose levels.
From: The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
Characteristic | All patients n = 421 | No hypoglycemia n = 331 | Hypoglycemia n = 90 |
|---|---|---|---|
Treatment location, n (%) | |||
General ward | 135 (32.1) | 115 (34.7) | 20 (22.2) |
Intensive care | 61 (14.5) | 55 (16.6) | 6 (6.7) |
Emergency department | 225 (53.4) | 161 (48.6) | 64 (71.1) |
Glucose quantitya, n (%) | |||
12.5 g | 36 (8.6) | 28 (8.5) | 8 (8.9) |
25 g (standard) | 382 (90.4) | 300 (90.6) | 82 (91.1) |
50 g | 3 (0.7) | 0 (0) | 3 (3.3) |
Short-acting insulin doseb, n (%) | |||
5–8 Units | 10 (2.4) | 8 (2.4) | 3 (2.2) |
10 Units (standard) | 407 (96.7) | 322 (97.3) | 85 (94.4) |
12–20 Units | 4 (1.0) | 3 (0.9) | 1 (1.1) |
Pre-treatment blood glucose, median (IQR), mmol/Lc | 7.9 (6.2–11.8) | 8.8 (6.6–12.0) | 6.5 (5.1–8.0) |
Trough blood glucose, median (IQR), mmol/L | 6.0 (4.3–9.1) | 7.0 (5.2–10.0) | 3.0 (2.5–3.5) |
Time to trough, median (IQR), min | 165 (93–266) | 180 (100–290) | 129 (90–200) |
Peak blood glucose, median (IQR), mmol/L | 10.0 (7.3) | 10.9 (7.6–15.5) | 8.3 (5.6–10.5) |
Time to peak, median (IQR), min | 105 (40–240) | 90 (37–227) | 160 (40–290) |
Trough blood glucose 3.0 to 3.8 mmol/L, n (%) | 45 (10.7) | N/A | 45 (50.0) |
Trough blood glucose < 3.0 mmol/L, n (%) | 45 (10.7) | N/A | 45 (50.0) |
Repeat treatment < 6 h, n (%) | 78 (18.5) | 60 (18.1) | 18 (20.0) |
